Zurich Cantonal Bank’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Zurich Cantonal Bank’s Portfolio PRTK Stock Details PRTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,688	Closed	-$9K	–	2635
2019 Q1	$9K	Hold	1,688	–	–	﹤0.01%	2521
2018 Q4	$9K	Hold	1,688	–	–	﹤0.01%	2553
2018 Q3	$16K	Hold	1,688	–	–	﹤0.01%	2509
2018 Q2	$17K	Hold	1,688	–	–	﹤0.01%	2446
2018 Q1	$22K	Hold	1,688	–	–	﹤0.01%	2391
2017 Q4	$30K	Buy	1,688 +1,011	+149%	+$21.1K	﹤0.01%	2294
2017 Q3	$17K	Hold	677	–	–	﹤0.01%	2314
2017 Q2	$16K	Hold	677	–	–	﹤0.01%	2326
2017 Q1	$13K	Hold	677	–	–	﹤0.01%	2434
2016 Q4	$10K	Sell	677 -2,530	-79%	-$32.8K	﹤0.01%	2456
2016 Q3	$42K	Buy	+3,207	New	+$42.5K	﹤0.01%	1757

Other funds holding PRTK

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HCMT

Highland Capital Management (Texas) Dallas, Texas $39M AUM

APCM

Arbiter Partners Capital Management New York $175M AUM 99.81% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

RAM

Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return

Zurich Cantonal Bank's PRTK Position: Q2 2019 in Review

Zurich Cantonal Bank sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q2 2019, closing a stake of 1,688 shares — an estimated $9K sold.

Zurich Cantonal Bank first reported a position in PRTK in Q3 2016 and held it in 11 quarters. The position peaked at $42K in Q3 2016. 89 funds tracked by Wall St. Rank hold PRTK as of Q2 2019.

Zurich Cantonal Bank reported no remaining Paratek Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
Zurich Cantonal Bank sold 1,688 Paratek Pharmaceuticals, Inc. shares in Q2 2019, an estimated $9K.
Zurich Cantonal Bank first reported a position in Paratek Pharmaceuticals, Inc. in Q3 2016 and held it in 11 quarters.
Zurich Cantonal Bank's Paratek Pharmaceuticals, Inc. position peaked at $42K in Q3 2016.
89 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q2 2019.

Based on Zurich Cantonal Bank's 13F filing for Q2 2019, filed 30 Jul 2019.